The RCOG is welcoming the latest findings on the variation in ovarian cancer treatment across England.
The ovarian cancer audit feasibility pilot – jointly funded by The British Gynaecological Cancer Society, Ovarian Cancer Action and Target Ovarian Cancer – published its latest findings on the variation in ovarian cancer treatment across England, for women diagnosed with the disease between 2016 and 2018.
The new report – using data from Public Health England and the National Cancer Registry – revealed significant regional differences in access to ovarian cancer treatment (particularly surgery) across the country.
The report revealed four in 10 women with ovarian cancer did not receive surgery, despite it being the treatment which offers the best long-term prognosis for women with the disease. A worrying one in five women diagnosed with ovarian cancer received no ovarian cancer treatment at all.
The research also uncovered a drop in access to treatments for older women across the country, with 37% of women above the age of 70 not receiving any treatment, rising to over 60% for those aged 80 and over.
Read the report: Ovarian Cancer Audit Feasibility Pilot: Outputs
Commenting on the audit report, Dr Edward Morris, President of the Royal College of Obstetricians and Gynaecologsts said:
"Ovarian cancer is one of the most common types of cancer in women and yet, as we can see from this report, many women aren’t being given the treatment they need to survive.
"What’s even more alarming is that where a woman lives and her age can have a significant impact on whether or not she is treated – something which is clearly contributing to the UK having one of the worst ovarian cancer survival rates in Europe.
"We still have a long way to go to understanding why such disparities exist when it comes to ovarian cancer care and we strongly support calls for a fully funded audit to investigate this further."